Which therapies are considered third-line for refractory urge incontinence?

• A. Antimuscarinic therapy
• B. Surgical cure with retropubic sling
• C. Pelvic floor training
• D. Sacral nerve stimulation or posterior tibial nerve stimulation; intradetrusor botox injections are also used.

Answer: (D)

Third-line choices for refractory urge incontinence are those that directly modulate bladder nerves or detrusor activity when lifestyle changes and medications haven’t provided relief. Sacral nerve stimulation and posterior tibial nerve stimulation alter the neural signals to the bladder, reducing urge and leakage episodes. Intradetrusor botox injections weaken the overactive detrusor muscle by blocking acetylcholine release, leading to fewer contractions and less incontinence. These approaches are more invasive or specialized than first-line behavioral therapies or second-line medications, which is why they sit at a higher tier in the treatment ladder.

Why the other options aren’t third-line: antimuscarinic therapy is a common second-line pharmacologic treatment, not a third-line option after previous steps fail. Pelvic floor training is a noninvasive, first-line strategy. A surgical sling targets stress urinary incontinence, not urge incontinence, so it’s not appropriate for this problem.